Israel
Taryag Medical is a company specializing in developing and manufacturing invasive vascular devices, with a focus on advanced PVD Therapeutic Solutions. Their flagship product, the ByCross device, offers an innovative alternative to bypass surgeries, effectively restoring blood flow in chronic total occlusion (CTO) without the need for a guide wire. Since its establishment in 2013, Taryag Medical has been dedicated to combating peripheral vascular disease through endovascular approaches. The company's commitment to innovation is evident in its continuous development of cutting-edge devices aimed at revolutionizing vascular disease care.
Despite a lack of explicit information regarding the company's headquarters and recent investments, Taryag Medical remains poised to attract substantial attention and support from venture capital firms and investors. With an emphasis on Health Care, Manufacturing, and Medical Devices, Taryag Medical holds significant potential for growth and impact within the healthcare industry.
